These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 6939879

  • 21. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC.
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [Abstract] [Full Text] [Related]

  • 22. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J, Alcorta I, Botey A, Revert L.
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [Abstract] [Full Text] [Related]

  • 23. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G, Bröll H, Eberl R.
    Wien Klin Wochenschr; 1973 Jan 26; 85(4):59-63. PubMed ID: 4567434
    [No Abstract] [Full Text] [Related]

  • 24. Editorial: D-penicillamine in rheumatoid arthritis.
    Lancet; 1975 May 17; 1(7916):1123-5. PubMed ID: 49477
    [No Abstract] [Full Text] [Related]

  • 25. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W, Pietruschka WD, Beenken O.
    Z Gesamte Inn Med; 1975 Aug 01; 30(15):507-9. PubMed ID: 1189496
    [Abstract] [Full Text] [Related]

  • 26. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
    Husain Z, Runge LA.
    J Rheumatol; 1980 Aug 01; 7(6):825-30. PubMed ID: 6451692
    [Abstract] [Full Text] [Related]

  • 27. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W, Gärtner HV, Kronenberg KH, Manz G.
    Schweiz Med Wochenschr; 1974 Mar 23; 104(12):434-8. PubMed ID: 4820540
    [No Abstract] [Full Text] [Related]

  • 28. [A case report of rheumatoid arthritis which showed acute renal failure, nephrotic syndrome and drug-related lupus-like syndrome caused by D-penicillamine].
    Suda M, Yoshikawa Y, Suzuki T, Dohi Y, Shibata T.
    Nihon Jinzo Gakkai Shi; 1990 Nov 23; 32(11):1235-41. PubMed ID: 2082056
    [Abstract] [Full Text] [Related]

  • 29. Dose-related nephrotic syndrome in penicillamine-treated rheumatoid arthritis.
    Spiera H.
    Mt Sinai J Med; 1984 Dec 23; 51(6):695-6. PubMed ID: 6335562
    [No Abstract] [Full Text] [Related]

  • 30. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA, de Arriba G, García-Martín F, Sánchez-Heras M, Giménez-Vega E, Sánchez J.
    Nefrologia; 2004 Dec 23; 24(2):183-7. PubMed ID: 15219094
    [Abstract] [Full Text] [Related]

  • 31. Penicillamine therapy in rheumatoid arthritis.
    Grobbelaar J, Meyers OL.
    S Afr Med J; 1984 May 05; 65(18):715-7. PubMed ID: 6719300
    [Abstract] [Full Text] [Related]

  • 32. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A, Anastassiades T.
    Clin Invest Med; 1984 May 05; 7(1):65-71. PubMed ID: 6426836
    [Abstract] [Full Text] [Related]

  • 33. [Pemphigus syndrome in D-penicillamine treated rheumatoid arthritis].
    Christoph R, Genth E, Grussendorf EI, Hartl PW.
    Med Welt; 1978 Nov 10; 29(45):1761-3. PubMed ID: 152378
    [No Abstract] [Full Text] [Related]

  • 34. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U, Bussmann HU, Jerusalem F.
    Schweiz Med Wochenschr; 1981 Jan 03; 111(1):29-35. PubMed ID: 6782670
    [Abstract] [Full Text] [Related]

  • 35. [D-penicillamine therapy in rheumatoid arthritis: adverse reactions with 2 different administration regimens].
    Fernández Dapica P, Peña J, Merino J, Casanueva B, Morillas L, Mateo I, Rodríguez-Valverde V, Gómez-Reino J.
    Med Clin (Barc); 1984 Jun 30; 83(5):184-7. PubMed ID: 6482577
    [No Abstract] [Full Text] [Related]

  • 36. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W, Keitel W.
    Z Rheumatol; 1988 Jun 30; 47 Suppl 1():44-7. PubMed ID: 3213272
    [Abstract] [Full Text] [Related]

  • 37. [Morphological pictures of renal biopsy specimens in glomerulopathies related to rheumatoid arthritis (RA)].
    Danilewicz M, Wagrowska-Danilewicz M.
    Przegl Lek; 1994 Jun 30; 51(1):5-8. PubMed ID: 8208996
    [Abstract] [Full Text] [Related]

  • 38. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H.
    Z Rheumatol; 1988 Jun 30; 47 Suppl 1():13-6. PubMed ID: 3063002
    [Abstract] [Full Text] [Related]

  • 39. The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients.
    Hall CL.
    Adv Exp Med Biol; 1989 Jun 30; 252():247-56. PubMed ID: 2782197
    [Abstract] [Full Text] [Related]

  • 40. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV.
    J Rheumatol Suppl; 1981 Jun 30; 7():103-6. PubMed ID: 6939871
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.